|
Market Closed -
OTC Markets
22:19:12 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0450 USD | -7.79% |
|
-16.67% | -26.53% |
| 08-13 | Radnostix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-25 | Radnostix, Inc. acquired Certain Assets of Lucerno Dynamics, LLC for 1.65 million. | CI |
| Market Cap | 23.81M 21.17M 19.62M 17.85M 33.68M 2.26B 34.22M 236M 92.46M 1.18B 89.37M 87.46M 3.76B | P/E 2024 |
2,150x | P/E 2025 | -35.5x |
|---|---|---|---|---|---|
| Enterprise Value | 31.02M 27.57M 25.56M 23.25M 43.88M 2.94B 44.58M 307M 120M 1.54B 116M 114M 4.9B | EV / Sales 2024 |
1.76x | EV / Sales 2025 | 3.03x |
| Free-Float |
26.54% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -7.79% | ||
| 1 week | -16.67% | ||
| Current month | -18.18% | ||
| 1 month | -25.00% | ||
| 3 months | -35.99% | ||
| 6 months | -45.81% | ||
| Current year | -26.53% |
| 1 week | 0.03 |  | 0.05 |
| 1 month | 0.03 | | 0.07 |
| Current year | 0.03 | | 0.1 |
| 1 year | 0.03 | | 0.11 |
| 3 years | 0.02 | | 0.11 |
| 5 years | 0.02 | | 0.11 |
| 10 years | 0 | | 0.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shahe Bagerdjian
CEO | Chief Executive Officer | 42 | 01/09/2023 |
W. Cox
DFI | Director of Finance/CFO | 42 | 30/09/2019 |
John Miller
LAW | General Counsel | 61 | 01/01/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 01/07/2017 | |
Steve Laflin
BRD | Director/Board Member | 69 | 01/06/2001 |
Robert Atcher
BRD | Director/Board Member | 74 | 02/08/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/10/25 A | Free | Director | 250,000 | 0.0478% | ||
| 10/10/25 A | Free | Chairman | 500,000 | 0.0955% | ||
| 10/10/25 A | Free | Director | 500,000 | 0.0955% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.79% | -16.67% | -18.18% | -15.09% | 23.81M | |
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | |
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | |
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | |
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | |
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | |
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | |
| Average | -0.94% | +3.25% | +29.15% | +53.62% | 394.09B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.34% | +71.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.9M 12.36M 11.45M 10.42M 19.66M 1.32B 19.98M 138M 53.97M 688M 52.17M 51.06M 2.19B | 13.07M 11.62M 10.77M 9.8M 18.49M 1.24B 18.78M 129M 50.75M 647M 49.05M 48.01M 2.06B |
| Net income | 8.57K 7.62K 7.06K 6.43K 12.13K 814K 12.32K 84.91K 33.29K 425K 32.18K 31.49K 1.35M | -908K -807K -748K -681K -1.28M -86.18M -1.3M -8.99M -3.53M -44.97M -3.41M -3.34M -143M |
| Net Debt | 6.42M 5.7M 5.29M 4.81M 9.08M 609M 9.22M 63.54M 24.91M 318M 24.08M 23.57M 1.01B | 7.21M 6.41M 5.94M 5.4M 10.19M 684M 10.36M 71.36M 27.98M 357M 27.04M 26.47M 1.14B |
Employees
45
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | $0.0450 | -7.79% | 80,000 |
| 13/10/26 | $0.0488 | -8.79% | 209,273 |
| 12/10/26 | $0.0535 | -0.93% | 178,488 |
| 09/10/26 | $0.0540 | 0.00% | 35,000 |
- Stock Market
- Stocks
- INIS Stock
Select your edition
All financial news and data tailored to specific country editions
